Levonorgestrel P Clydesdale Pharma

Levonorgestrel, the active ingredient in Levonorgestrel P Clydesdale Pharma, is a progestogen presented as an oral tablet for systemic use. It is employed to prevent pregnancy, both as an emergency contraceptive after unprotected intercourse and as a regular hormonal contraceptive for ongoing birth control.\n\nGNH India supplies Levonorgestrel P Clydesdale Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and offers reliable logistics to ensure consistent global distribution of the product.

Levonorgestrel is a progestogen used in hormonal contraceptive pathways to prevent pregnancy.\n\n- Emergency contraception: prevents pregnancy when taken within a defined time after unprotected sexual intercourse by inhibiting ovulation and altering the endometrium.\n- Regular hormonal contraception: provides ongoing birth control by suppressing ovulation and thickening cervical mucus to reduce sperm penetration.\n- Menstrual cycle regulation: can be used to delay or modify the timing of menstruation in women seeking cycle control.

Levonorgestrel may cause a range of adverse reactions, varying from mild to severe.\n\nCommon Side Effects:\n- Nausea\n- Headache\n- Abdominal pain or cramps\n- Breast tenderness\n- Menstrual spotting or changes\n\nSerious or Rare Side Effects:\n- Thromboembolic events (deep vein thrombosis, pulmonary embolism)\n- Severe allergic reactions (anaphylaxis, angioedema)\n- Liver dysfunction or jaundice

When prescribing or dispensing levonorgestrel, several safety considerations should be observed.\n- Contraindication assessment: verify no known hypersensitivity to levonorgestrel or other progestins.\n- Medical review: ensure patient is not pregnant and has no active thromboembolic disorder.\n- Hepatic function: use with caution in patients with severe liver disease.\n- Drug interactions: review concomitant medications that may reduce efficacy, such as enzyme inducers.\n- Smoking status: advise against use in women over 35 who smoke heavily.\n- Store at below 25°C: keep tablets in the original packaging, protect from moisture and direct sunlight.

Levonorgestrel can interact with other medicines, affecting its effectiveness or safety.\n\nMajor Interactions (Avoid):\n- Rifampin and other strong enzyme inducers: significantly reduce levonorgestrel plasma levels.\n- Antiepileptic drugs (carbamazepine, phenytoin, phenobarbital): may decrease contraceptive effectiveness.\n- St. John’s wort: herbal inducer that can lower drug exposure.\n\nModerate Interactions (Monitor Closely):\n- Antifungal agents (ketoconazole, itraconazole): may increase levonorgestrel levels, monitor for side effects.\n- Antibiotics (rifabutin, griseofulvin): may modestly affect efficacy, advise backup contraception.\n- Hormonal therapies (combined oral contraceptives, hormone replacement): assess cumulative hormonal load and adjust dosing if needed.